trouble sleeping; fever 101.7; chills; fatigue; pain and swelling at injection site; pain and swelling at injection site; swollen lymph nodes under arms and in neck; sore throat; ear pain; joint pain; This is a spontaneous report from a contactable consumer. The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 03Nov2021 14:15 (Lot number: EW0217) at the age of 47 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "contact dermatitis" (unspecified if ongoing); "eczema" (unspecified if ongoing), notes: eczema; "anxiety" (unspecified if ongoing), notes: anxiety; "depression" (unspecified if ongoing), notes: depression. Concomitant medication(s) included: SERTRALINE; VOLNEA; FLUTICASONE PROPIONATE (GLUCOCORTICOID); MAGNESIUM POLYGALACTURONATE; DOXYCYCLINE PHOSPHATE; FISH OIL OMEGA 3; VITAMIN D COMPLEX; BOOSTRIX, start date: 21Oct2021; FLUARIX QUADRIVALENT, start date: 21Oct2021. Past drug history included: Kown allergies: lanolin, reaction(s): "Allergy"; Known allergies: thimerosal, reaction(s): "Allergy"; Known allergies: nickel, reaction(s): "Allergy"; Known allergies:vinyl, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3247, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 17Feb2021, when the patient was 47 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 26Jan2021, when the patient was 47 years old, for COVID-19 Immunization. The following information was reported: INSOMNIA (non-serious) with onset 04Nov2021 06:00, outcome "recovering", described as "trouble sleeping"; PYREXIA (non-serious) with onset 04Nov2021 06:00, outcome "recovering", described as "fever 101.7"; CHILLS (non-serious) with onset 04Nov2021 06:00, outcome "recovering", described as "chills"; FATIGUE (non-serious) with onset 04Nov2021 06:00, outcome "recovering", described as "fatigue"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset 04Nov2021 06:00, outcome "recovering" and all described as "pain and swelling at injection site"; LYMPHADENOPATHY (non-serious) with onset 04Nov2021 06:00, outcome "recovering", described as "swollen lymph nodes under arms and in neck"; OROPHARYNGEAL PAIN (non-serious) with onset 04Nov2021 06:00, outcome "recovering", described as "sore throat"; EAR PAIN (non-serious) with onset 04Nov2021 06:00, outcome "recovering", described as "ear pain"; ARTHRALGIA (non-serious) with onset 04Nov2021 06:00, outcome "recovering", described as "joint pain". Therapeutic measures were taken as a result of insomnia, pyrexia, chills, fatigue, vaccination site pain, vaccination site swelling, lymphadenopathy, oropharyngeal pain, ear pain, arthralgia.   Additional information:-The patient had not covid prior to vaccination. and had not done covid tested post vaccination.Prior to vaccination,the patient did not diagnosed with COVID-19 and since the vaccination,the patient had not been tested for COVID-19.The patient had no seriousness criteria.  No follow-up attempts are possible. No further information is expected.